← Leaderboards
Mark E Anderson
Vanderbilt University
$21,768,068
Attributed
$21,768,068
Total exposure
16
Grants
14
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.5M · FY2005–22$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$21,768,068 · 16
By mechanism
R01$15,262,825 · 5
R35$5,218,606 · 1
P01$1,033,482 · 2
K08$221,454 · 1
R13$20,000 · 2
P41$11,701 · 5
Top collaborators
No co-investigators on record.
Most similar at Vanderbilt University
Same institution · by research overlap
- Joey V Barnett$14,020,110
- Ann Richmond$15,857,391
- Todd R Graham$10,608,745
- Randy D Blakely$29,330,449
- Madelaine Paige Thorpe$53,348
Others in their field
Top investigators on “Signal Transduction”
- Peter B. Gilbert · Fred Hutchinson Cancer Center$148,539,615
- David Heimbrook · Leidos Biomedical Research, Inc.$82,049,940
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$70,290,471
- Garret A Fitzgerald · University Of Pennsylvania$66,142,222
- Michael Barry Kastan · Duke University$64,512,357
- Randall J Bateman · Washington University$62,939,456
Research focus
Signal TransductionArrhythmiaInnovationPreventPathway InteractionsHeart FailureCalmodulin-Dependent Protein Kinase IiFigs - DietaryMolecularResponseMouse ModelMyocardialPhysiologyHeartReactive Oxygen SpeciesPhosphorylationCessation Of LifePublic Health Medicine (Field)In VivoMuscle CellsPhysiologicalCardiac MyocytesCa(2+)-Calmodulin Dependent Protein KinaseMitochondria
Grant awards (68)
CaMKII signaling in physiology, heart failure and arrhythmias$963,586
R35 · FY2022 · HL · contact PI
CaMKII signaling in physiology, heart failure and arrhythmias$1,198,563
R35 · FY2021 · HL · contact PI
CaMKII signaling in physiology, heart failure and arrhythmias$935,408
R35 · FY2020 · HL · contact PI
CaMKII signaling in physiology, heart failure and arrhythmias$234,981
R35 · FY2020 · HL · contact PI
CaMKII signaling in physiology, heart failure and arrhythmias$935,410
R35 · FY2019 · HL · contact PI
CaMKII signaling in physiology, heart failure and arrhythmias$950,658
R35 · FY2018 · HL · contact PI
Mitochondrial Calmodulin Kinase II in Physiology and Disease$393,845
R01 · FY2017 · HL · contact PI
Oxidized CaMKII in Atrial Fibrillation$405,000
R01 · FY2016 · HL · contact PI
Mitochondrial Calmodulin Kinase II in Physiology and Disease$393,845
R01 · FY2016 · HL · contact PI
CaMKII in Sinus Node Physiology and Disease$387,916
R01 · FY2016 · HL · contact PI
Oxidized CaMKII in Atrial Fibrillation$398,925
R01 · FY2015 · HL · contact PI
Mitochondrial Calmodulin Kinase II in Physiology and Disease$392,217
R01 · FY2015 · HL · contact PI
CaMKII in Sinus Node Physiology and Disease$382,097
R01 · FY2015 · HL · contact PI
Methionine sulfoxide reductase A and oxidized CaMKII in structural heart disease$364,500
R01 · FY2015 · HL · contact PI
Mitochondrial Calmodulin Kinase II in Physiology and Disease$396,900
R01 · FY2014 · HL · contact PI
CaMKII in Sinus Node Physiology and Disease$395,316
R01 · FY2014 · HL · contact PI
Oxidized CaMKII in Atrial Fibrillation$369,950
R01 · FY2014 · HL · contact PI
Methionine sulfoxide reductase A and oxidized CaMKII in structural heart disease$369,950
R01 · FY2014 · HL · contact PI
2014 Cardiac Regulatory Mechanisms Gordon Research Conference & Gordon Research S$10,000
R13 · FY2014 · HL · contact PI
Oxidized CaMKII in Atrial Fibrillation$359,380
R01 · FY2013 · HL · contact PI
Mitochondrial Calmodulin Kinase II in physiology and disease$359,380
R01 · FY2013 · HL · contact PI
CaMKII in Sinus Node Physiology and Disease$359,380
R01 · FY2013 · HL · contact PI
Methionine sulfoxide reductase A and oxidized CaMKII in structural heart disease$359,380
R01 · FY2013 · HL · contact PI
Methionine sulfoxide reductase A and oxidized CaMKII in structural heart disease$377,500
R01 · FY2012 · HL · contact PI
Oxidized CaMKII in Atrial Fibrillation$377,500
R01 · FY2012 · HL · contact PI
Cardiac-Targeted Calmodulin Kinase II Inhibition$371,250
R01 · FY2012 · HL · contact PI
CaMKII in Sinus Node Physiology and Disease$371,250
R01 · FY2012 · HL · contact PI
2012 Cardiac Regulatory Mechanisms Gordon Research Conference and Gordon Research$10,000
R13 · FY2012 · HL · contact PI
Methionine sulfoxide reductase A and oxidized CaMKII in structural heart disease$376,042
R01 · FY2011 · HL · contact PI
Cardiac-Targeted Calmodulin Kinase II Inhibition$375,000
R01 · FY2011 · HL · contact PI
CaMKII in Sinus Node Physiology and Disease$375,000
R01 · FY2011 · HL · contact PI
CaMKII in Sinus Node Physiology and Disease$375,000
R01 · FY2010 · HL · contact PI
Cardiac-Targeted Calmodulin Kinase II Inhibition$375,000
R01 · FY2010 · HL · contact PI
Cardiac-Targeted Calmodulin Kinase II Inhibition$375,000
R01 · FY2009 · HL · contact PI
CaMKII in Sinus Node Physiology and Disease$375,000
R01 · FY2009 · HL · contact PI
Angiotensin II, Aldosterone, Oxidation, and CaMKII in Hypertrophy and Arrhythmias$358,056
R01 · FY2009 · HL · contact PI
RUNNING POSSIBLE COLLABORATORY EXPERIMENTS$1,528
P41 · FY2009 · RR · contact PI
TESTING AND CALIBRATION OF SPECTROMETER FUNCTIONS$68
P41 · FY2009 · RR · contact PI
Cardiac-Targeted Calmodulin Kinase II Inhibition$375,000
R01 · FY2008 · HL · contact PI
Angiotensin II, Aldosterone, Oxidation, and CaMKII in Hypertrophy and Arrhythmias$358,056
R01 · FY2008 · HL · contact PI
TESTING AND CALIBRATION OF SPECTROMETER FUNCTIONS$1,477
P41 · FY2008 · RR · contact PI
RUNNING POSSIBLE COLLABORATORY EXPERIMENTS$1,095
P41 · FY2008 · RR · contact PI
Angiotensin II, Aldosterone, Oxidation, and CaMKII in Hypertrophy and Arrhythmias$358,056
R01 · FY2007 · HL · contact PI
Calmodulin Kinase II and Early Afterdepolarizations$244,750
R01 · FY2007 · HL · contact PI
Angiotensin II, Aldosterone, Oxidation, and CaMKII in Hypertrophy and Arrhythmias$368,750
R01 · FY2006 · HL · contact PI
Calmodulin Kinase II and Early Afterdepolarizations$252,060
R01 · FY2006 · HL · contact PI
Core--Cellular and mouse surgical$180,499
P01 · FY2006 · HL · contact PI
Calmodulin kinase and arrhythmias in cardiomyopathy$180,499
P01 · FY2006 · HL · contact PI
Cardiac-targeted Calmodulin Kinase II Inhibition$301,733
R01 · FY2005 · HL
Calmodulin Kinase II and Early Afterdepolarizations$264,250
R01 · FY2005 · HL
Core--Cellular and mouse surgical$175,005
P01 · FY2005 · HL
Calmodulin kinase and arrhythmias in cardiomyopathy$175,005
P01 · FY2005 · HL
Cardiac-targeted Calmodulin Kinase II Inhibition$45,435
R01 · FY2005 · HL
Cardiac-targeted Calmodulin Kinase II Inhibition$352,000
R01 · FY2004 · HL
Calmodulin Kinase II and Early Afterdepolarizations$264,250
R01 · FY2004 · HL
Cardiac-targeted Calmodulin Kinase II Inhibition$352,000
R01 · FY2003 · HL
Calmodulin Kinase II and Early Afterdepolarizations$287,312
R01 · FY2003 · HL
Cardiac-targeted Calmodulin Kinase II Inhibition$344,582
R01 · FY2002 · HL
CALMODULIN KINASE II AND EARLY AFTERDEPOLARIZATIONS$226,929
R01 · FY2002 · HL
Calmodulin kinase and arrhythmias in cardiomyopathy$161,237
P01 · FY2002 · HL
Core--Cellular and mouse surgical$161,237
P01 · FY2002 · HL
DEVELOPMENT OF NMR PROBES FOR PHYSIOLOGY$0
P41 · FY2002 · RR
CALMODULIN KINASE II AND EARLY AFTERDEPOLARIZATIONS$151,183
R01 · FY2001 · HL
CALMODULIN KINASE II AND EARLY AFTER DEPOLARIZATIONS$110,727
K08 · FY2001 · HL
DEVELOPMENT OF NMR PROBES FOR PHYSIOLOGY$0
P41 · FY2001 · RR
CALMODULIN KINASE II AND EARLY AFTERDEPOLARIZATIONS$146,900
R01 · FY2000 · HL
CALMODULIN KINASE II AND EARLY AFTER DEPOLARIZATIONS$110,727
K08 · FY2000 · HL
DEVELOPMENT OF NMR PROBES FOR PHYSIOLOGY$7,533
P41 · FY2000 · RR